Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 157
  • Home
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2021  |  Volume : 8  |  Issue : 3  |  Page : 228-236

Days Spent at Home near the End of Life in Japanese Elderly Patients with Lung Cancer: Post hoc Analysis of a Prospective Study


1 Clinical Research Center, Shizuoka Cancer Center, Shizuoka; Graduate School, Oita University of Nursing and Health Sciences, Oita, Japan
2 Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan
3 Clinical Research Center, Shizuoka Cancer Center, Shizuoka, Japan
4 Division of Rehabilitation Medicine, Shizuoka Cancer Center, Shizuoka, Japan
5 Division of Nursing, Shizuoka Cancer Center, Shizuoka, Japan
6 Tachikawa Faculty of Nursing, Tokyo Healthcare University, Tokyo, Japan
7 Department of Environmental Health Science, Oita University of Nursing and Health Sciences, Oita, Japan

Correspondence Address:
Tateaki Naito
Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka
Japan
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2347-5625.311131

Rights and Permissions

Objective: Days spent at home (DASH) near the end of life is considered an important patient-centered goal and outcome because many patients want to stay at home toward the end of life. This study aimed to estimate the individual DASH near the end of life and identify its early predictors, including muscle mass and physical function, among elderly patients with advanced non-small-cell lung cancer (NSCLC). Methods: We conducted a post hoc analysis of the prospective observational study (UMIN000009768) that recruited patients aged ≥ 70 years who were scheduled to undergo first-line chemotherapy because of advanced NSCLC. We measured the muscle mass by bioelectrical impedance analysis at baseline. DASH was calculated as 30 days minus the number of days spent in hospitals, palliative care facilities, or nursing homes during the last 30 days of life. We performed linear regression analyses to evaluate the predictors of DASH. Results: Altogether, 16 women and 28 men with a median overall survival of 15.5 months (range: 2.9–58.9) were included. The median DASH in the last 30 days of life was 8 days (range: 0–30, interquartile range: 0–23). Men had longer DASH than women by 7.3 days. Patients who had good trunk muscle mass index and hand-grip strength had significantly longer DASH than those who did not (4.7 days per kg/m2 increase [P = 0.017] and 0.4 days per kg increase [P = 0.032], respectively). Conclusions: Most elderly patients with advanced NSCLC had a limited DASH near the end of life. The risk factors for reduced DASH were women, reduced muscle mass, and poor physical function at the time of diagnosis of advanced NSCLC. Our findings would encourage early discussions about end-of-life care for patients with advanced cancers with risk factors for short DASH at the time of diagnosis, and thus, improve the quality of end-of-life care.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1299    
    Printed22    
    Emailed0    
    PDF Downloaded94    
    Comments [Add]    

Recommend this journal